Rapid Remission With Upadacitinib in a Child With Refractory Crohn's Disease and ATM Mutation: A Case Report

ABSTRACT: Managing pediatric Crohn's disease (PCD) presents challenges due to severe complications and higher biologic therapy needs. Transitioning from anti–tumor necrosis factor agents to off-label therapies adds complexity. Although upadacitinib has demonstrated efficacy and tolerability in adult...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yan Liu, MD, XiaoMei Song, MD, LingYa Xiang, MD, Wei Tan, MD, Min Zou, MD, Hong Guo, MD
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2024-01-01
סדרה:	Current Therapeutic Research
נושאים:	ataxia telangiectasia mutated case report child refractory Crohn's disease upadacitinib
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S0011393X24000262
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!